555
Participants
Start Date
April 29, 2016
Primary Completion Date
July 1, 2019
Study Completion Date
March 11, 2021
Secukinumab
Induction: 4x 150 mg Secukinumab s.c. weekly Maintenance: 150 mg Secukinumab s.c. monthly
Placebo
Induction: 4x placebo s.c. weekly Maintenance: placebo s.c. monthly
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Moss
Novartis Investigative Site, Sofia
Novartis Investigative Site, Fribourg
Novartis Investigative Site, Sofia
Novartis Investigative Site, Kongsvinger
Novartis Investigative Site, Coffs Harbour
Novartis Investigative Site, Malvern East
Novartis Investigative Site, Eger
Novartis Investigative Site, Genk
Novartis Investigative Site, Basel
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Maroochydore
Novartis Investigative Site, Pleven
Novartis Investigative Site, Szeged
Novartis Investigative Site, Hobart
Novartis Investigative Site, Székesfehérvár
Novartis Investigative Site, Graz
Novartis Investigative Site, Veszprém
Novartis Investigative Site, Ghent
Novartis Investigative Site, Albany
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Potsdam
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Potsdam
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Duncansville
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Torreón
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Novara
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Málaga
Novartis Investigative Site, Charleston
Novartis Investigative Site, Hanover
Novartis Investigative Site, Gainesville
Novartis Investigative Site, Bordeaux
Novartis Investigative Site, Padua
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Vigo
Novartis Investigative Site, Verona
Novartis Investigative Site, Chambray-lès-Tours
Novartis Investigative Site, Santander
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Bologna
Novartis Investigative Site, Seville
Novartis Investigative Site, Bowling Green
Novartis Investigative Site, Guadalajara
Novartis Investigative Site, Herne
Novartis Investigative Site, Valencia
Novartis Investigative Site, Bilbao
Novartis Investigative Site, Lansing
Novartis Investigative Site, Metepec
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Pisa
Novartis Investigative Site, Great Falls
Novartis Investigative Site, Brno-Zidonice
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, Mesquite
Novartis Investigative Site, Paris
Novartis Investigative Site, Rouen
Novartis Investigative Site, Leander
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Culiacan
Novartis Investigative Site, Denver
Novartis Investigative Site, Idaho Falls
Novartis Investigative Site, Poitiers
Novartis Investigative Site, Limoges
Novartis Investigative Site, Beverly Hills
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Boulogne-Billancourt
Novartis Investigative Site, Fullerton
Novartis Investigative Site, Portland
Novartis Investigative Site, Monaco
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Smolensk
Novartis Investigative Site, Saratov
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Kemerovo
Novartis Investigative Site, Barnaul
Novartis Investigative Site, Haifa
Novartis Investigative Site, Kfar Saba
Novartis Investigative Site, Braga
Novartis Investigative Site, Tel Aviv
Novartis Investigative Site, Woolloongabba
Novartis Investigative Site, Vienna
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Prague
Novartis Investigative Site, Brno
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Cottbus
Novartis Investigative Site, Dresden
Novartis Investigative Site, Kita-gun
Novartis Investigative Site, Kawachi-Nagano
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Meguro City
Novartis Investigative Site, Shinjuku Ku
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Groningen
Novartis Investigative Site, Maastricht
Novartis Investigative Site, Krakow
Novartis Investigative Site, Poznan
Novartis Investigative Site, Poznan
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Almada
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Ponte de Lima
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Elda
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Gothenburg
Novartis Investigative Site, Lund
Novartis Investigative Site, Uppsala
Novartis Investigative Site, Ankara
Novartis Investigative Site, Westcliff-on-Sea
Novartis Investigative Site, Leytonstone
Novartis Investigative Site, Stoke-on-Trent
Novartis Investigative Site, Worthing
Novartis Investigative Site, Bath
Novartis Investigative Site, Doncaster
Novartis Investigative Site, Middlesbrough
Novartis Investigative Site, Northampton
Novartis Investigative Site, Wolverhampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY